Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-30

Clinical Trial Update: A Clinical Trial to Evaluate the Food Effect of CKD-379 [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the effect of food on CKD-379 in Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CKD-379

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Type II Diabetes Mellitus | Phase 1 | Status: COMPLETED